Last mentioned: Mar 5, 2026
Keynote Announcement
Jose Carmena announced as keynote for the 2026 Bioelectronic Medicine Forum in NYC.
Astellas Acquisition
Astellas Pharma acquires Iota Biosciences to bolster its 'Rx+' innovation strategy.
Iota Biosciences Founded
Jose Carmena and Michel Maharbiz spin out 'neural dust' technology from UC Berkeley.
Jose Carmena, co-founder of Iota Biosciences, has been named the keynote speaker for the 2026 Bioelectronic Medicine Forum in New York City. The event highlights the accelerating shift toward ultrasound-powered 'neural dust' and minimally invasive neuromodulation therapies.
The founder of Iota Biosciences has been named the keynote speaker for the 2026 Bioelectronic Medicine Forum in New York City. This announcement highlights the growing prominence of 'neural dust' technology and its potential to revolutionize chronic disease management through ultra-miniature bioelectronic implants.